- Filed
- May 17, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2024 · May 17, 2024 | 76.09M sh |
| Shares Diluted | Q3 2024 · Mar 31, 2024 | 19.07M sh |
| Shares Diluted | Q3 2024 · Mar 31, 2023 | 9.11M sh |
| Operating Cash Flow | Q3 2024 · Mar 31, 2024 | −$673.96K |
| Operating Cash Flow | Q3 2024 · Mar 31, 2023 | −$1.19M |
| Stockholders Equity | Q3 2024 · Mar 31, 2024 | −$1.43M |
| Stockholders Equity | Q3 2024 · Dec 31, 2023 | −$1.34M |
| Stockholders Equity | Q3 2024 · Jun 30, 2023 | −$784.5K |
| Stockholders Equity | Q3 2024 · Mar 31, 2023 | −$142.27K |
| Stockholders Equity | Q3 2024 · Dec 31, 2022 | −$245.77K |
| Stockholders Equity | Q3 2024 · Jun 30, 2022 | $463.27K |
| Total Liabilities | Q3 2024 · Mar 31, 2024 | $1.53M |
| Total Liabilities | Q3 2024 · Jun 30, 2023 | $1.02M |
| Current Assets | Q3 2024 · Mar 31, 2024 | $82.5K |
| Current Assets | Q3 2024 · Jun 30, 2023 | $211.47K |
| Total Assets | Q3 2024 · Mar 31, 2024 | $107.5K |
| Total Assets | Q3 2024 · Jun 30, 2023 | $236.47K |
| Sga Expense | Q3 2024 · Mar 31, 2024 | $652.64K |
| Sga Expense | Q3 2024 · Mar 31, 2024 | $2.47M |
| Sga Expense | Q3 2024 · Mar 31, 2023 | $2.18M |
| Sga Expense | Q3 2024 · Mar 31, 2023 | $3.86M |
| Net Income | Q3 2024 · Mar 31, 2024 | −$1.06M |
| Net Income | Q3 2024 · Mar 31, 2024 | −$7.39M |
| Net Income | Q3 2024 · Mar 31, 2023 | −$4.85M |
| Net Income | Q3 2024 · Mar 31, 2023 | −$7.5M |
| Operating Income | Q3 2024 · Mar 31, 2024 | $681.46K |
| Operating Income | Q3 2024 · Mar 31, 2024 | $2.62M |
| Operating Income restated | Q3 2024 · Mar 31, 2023 | $2.63M |
| Operating Income restated | Q3 2024 · Mar 31, 2023 | $4.7M |
| Revenue | Q3 2024 · Mar 31, 2024 | $0 |
| Revenue | Q3 2024 · Mar 31, 2024 | $24.96K |
| Revenue | Q3 2024 · Mar 31, 2023 | $0 |
| Revenue | Q3 2024 · Mar 31, 2023 | $0 |